NantHealth, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NantHealth, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q4 2022.
  • NantHealth, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $1.12M, a 16.6% decline year-over-year.
  • NantHealth, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $4.67M, a 20% increase year-over-year.
  • NantHealth, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.67M, a 20% increase from 2021.
  • NantHealth, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.89M, a 46.8% increase from 2020.
  • NantHealth, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $2.65M, a 4.95% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $4.67M $1.12M -$224K -16.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-14
Q3 2022 $4.89M $889K +$91K +11.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $4.8M $1.26M +$408K +47.7% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $4.39M $1.39M +$503K +56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $3.89M $1.35M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 $798K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $855K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $887K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2019 $2.79M $937K +$86K +10.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $2.7M $526K +$153K +41% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $2.55M $673K -$1.14M -62.8% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $3.68M $650K -$1.98M -75.2% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $5.66M $851K -$7.73M -90.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $13.4M $373K +$5.34M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $8.06M $1.81M +$1.17M +183% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $6.89M $2.63M +$2.38M +950% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $4.51M $8.58M +$3.62M +72.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $896K -$4.96M -$10.2M -196% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-21
Q2 2017 $11.1M $639K -$43.1M -98.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $54.1M $250K +$152K +155% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $54M $4.97M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $5.19M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $43.7M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $98K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.